Friday Apr 18
Diabetes Self Management
FDA Approves Weekly Type 2 Diabetes Medicine
On April 15, the US Food and Drug Administration approved the once-weekly injectable Type 2 diabetes medicine albiglutide , developed by GlaxoSmithKline .
Wed Apr 16, 2014
Albiglutide Approved for Type 2 Diabetes
The once-weekly therapy is indicated, in conjunction with diet and exercise, to improve glycemic control.
Tue Apr 15, 2014
Canine cancer study aimed at improving survival for humans and dogs
Dr. Troy Harkness has received a Canadian Cancer Society Innovation Grant to investigate a new strategy to overcome treatment resistance in cancers.
Tue Apr 08, 2014
MicroBiome Therapeutics LLC' Clinical Trial Data For NM504 In Type 2...
MicroBiome Therapeutics LLC ' Clinical Trial Data For NM504 In Type 2 Diabetes Has Been Accepted For Presentation At ICE/ENDO 2014 /PRNewswire/ -- MicroBiome TherapeuticsTM LLC, today announced that data from the company's clinical trial of microbiome modulator NM504 in development for type 2 diabetes and prediabetes has been accepted for a Poster ... (more)
Sat Apr 05, 2014
Mail on Sunday
The vitamins you CAN mix with medication
We are often warned that supplements can be dangerous when mixed with medication.
Thu Apr 03, 2014
Canine cancer treatment to help humans
Cancer research is being conducted at the University of Saskatchewan veterinary college using dogs.
Wed Apr 02, 2014
U of S treating dogs with cancer to help improve treatment for people
Researchers at the University of Saskatchewan are hoping to learn more about extending the lives of people with drug resistant cancer by extending the lives of dogs.
Mon Mar 31, 2014
Mental Help Net
Diabetes Treatment Falls Short as Heart Failure Drug in Study
A drug commonly used to treat diabetes does not help prevent heart failure in non-diabetics who've had a heart attack, according to a new study.
Metformin fails to reduce heart failure after heart attack
The use of metformin, a common regulator of blood glucose for diabetics, does not help protect against heart failure in non-diabetic patients who have suffered a heart attack, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
Metformin does not improve heart function in patients without diabetes
Although some research has suggested that metformin, a medication often used in the treatment of diabetes, may have favorable effects on ventricular function, among patients without diabetes who underwent percutaneous coronary intervention for ST-segment elevation myocardial infarction , treatment with metformin did not result in improved ... (more)
Sun Mar 30, 2014
Study: Heavy teens have trouble...
New research sends a stark warning to overweight teens: If you develop diabetes, you'll have a very tough time keeping it under control.
Thu Mar 27, 2014
GlaxoSmithKline Receives European Authorisation For Once-Weekly Type...
GSK receives European authorisation for once-weekly type 2 diabetes treatment, EperzanA 26 March 2014, London UK -- GlaxoSmithKline plc today announced that the European Commission has granted marketing authorisation for its once-weekly diabetes treatment, EperzanA .
Crystal Research Associates, LLC Issues Executive Informational...
Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview on Boston Therapeutics, Inc. .
Wed Mar 26, 2014
Patent Issued for Method and Apparatus for Distributing a Composite...
Of the estimated 20.6 million individuals with diabetes, approximately thirty percent of them are undiagnosed.